This continuous survey (The Clinical Trials Implementation Monitor, or “CTiMonitor”) aims to build knowledge on how the implementation of the Clinical Trials Regulation (CTR), (EU) No. 536/2014 is progressing in different European countries. This information is of interest to various stakeholders including Pharmaceutical Industry, Regulators, the Commission and national Ministries The first survey round was sent to the EFPIA National Trade Associations (NTAs) Regulatory Network with a possibility to respond between 14.11.-1.12.2014 and will be repeated quarterly until mid 2016.